|
MechanismGABAB receptor modulators |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ RecruitingEarly Phase 1IIT A multicentre, randomised controlled study of a self-proposed Wenyangtongluo Fang for the treatment of oxaliplatin-associated peripheral neurotoxicity
/ Not yet recruitingNot ApplicableIIT Effect of perioperative application of tozumab on the prognosis of CAS in patients with severe symptomatic carotid stenosis
100 Clinical Results associated with STUDY GROUP UK LTD
0 Patents (Medical) associated with STUDY GROUP UK LTD
100 Deals associated with STUDY GROUP UK LTD
100 Translational Medicine associated with STUDY GROUP UK LTD